CHF 16.0 million cash & cash equivalents, trade and other receivables as at June 30, 2020 Revenues increased to CHF 1.3 million driven by strong MagnetOs sales, up 42% versus […]
Autor: Firma Kuros Biosciences
Kuros Biosciences further strengthens orthobiologics patent portfolio
. Grant of European patent entitled ‘Osteoinductive composites’ Notice of allowance of Japanese patent from the same patent family Further strengthens Kuros’s position as a leader in the field of […]